Plus Therapeutics Stock Price History
PSTV Stock | USD 1.23 0.05 4.24% |
Below is the normalized historical share price chart for Plus Therapeutics extending back to July 11, 2001. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Plus Therapeutics stands at 1.23, as last reported on the 26th of November, with the highest price reaching 1.25 and the lowest price hitting 1.16 during the day.
If you're considering investing in Plus Stock, it is important to understand the factors that can impact its price. Plus Therapeutics maintains Sharpe Ratio (i.e., Efficiency) of -0.0119, which implies the firm had a -0.0119% return per unit of risk over the last 3 months. Plus Therapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Plus Therapeutics' Coefficient Of Variation of (6,528), insignificant risk adjusted performance, and Variance of 32.21 to confirm the risk estimate we provide.
At this time, Plus Therapeutics' Common Stock Shares Outstanding is fairly stable compared to the past year. Preferred Stock And Other Adjustments is likely to climb to about 893 K in 2024, whereas Liabilities And Stockholders Equity is likely to drop slightly above 10.8 M in 2024. . Price To Sales Ratio is likely to drop to 1.06 in 2024. Price Earnings Ratio is likely to drop to -0.43 in 2024. Plus Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 16th of November 2000 | 200 Day MA 1.7014 | 50 Day MA 1.382 | Beta 0.69 |
Plus |
Sharpe Ratio = -0.0119
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | PSTV |
Estimated Market Risk
5.76 actual daily | 51 51% of assets are less volatile |
Expected Return
-0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Plus Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Plus Therapeutics by adding Plus Therapeutics to a well-diversified portfolio.
Price Book 3.7603 | Enterprise Value Ebitda (0.30) | Price Sales 1.3165 | Shares Float 5.7 M | Wall Street Target Price 16 |
Plus Therapeutics Stock Price History Chart
There are several ways to analyze Plus Stock price data. The simplest method is using a basic Plus candlestick price chart, which shows Plus Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | September 27, 2024 | 1.85 |
Lowest Price | November 15, 2024 | 1.17 |
Plus Therapeutics November 26, 2024 Stock Price Synopsis
Various analyses of Plus Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Plus Stock. It can be used to describe the percentage change in the price of Plus Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Plus Stock.Plus Therapeutics Price Action Indicator | 0.05 | |
Plus Therapeutics Price Daily Balance Of Power | 0.56 | |
Plus Therapeutics Price Rate Of Daily Change | 1.04 |
Plus Therapeutics November 26, 2024 Stock Price Analysis
Plus Stock Price History Data
The price series of Plus Therapeutics for the period between Wed, Aug 28, 2024 and Tue, Nov 26, 2024 has a statistical range of 0.68 with a coefficient of variation of 9.16. The price distribution for the period has arithmetic mean of 1.39. The median price for the last 90 days is 1.38. The company completed stock split (1:15) on 1st of May 2023. Plus Therapeutics had dividends distributed to its stock-holders on 2019-08-06.Open | High | Low | Close | Volume | ||
11/26/2024 | 1.20 | 1.25 | 1.16 | 1.23 | ||
11/25/2024 | 1.20 | 1.25 | 1.16 | 1.23 | 115,190 | |
11/22/2024 | 1.18 | 1.23 | 1.12 | 1.18 | 461,578 | |
11/21/2024 | 1.22 | 1.22 | 1.16 | 1.20 | 26,960 | |
11/20/2024 | 1.22 | 1.24 | 1.19 | 1.19 | 15,757 | |
11/19/2024 | 1.22 | 1.24 | 1.18 | 1.24 | 36,948 | |
11/18/2024 | 1.21 | 1.21 | 1.17 | 1.19 | 28,199 | |
11/15/2024 | 1.28 | 1.29 | 1.16 | 1.17 | 133,322 | |
11/14/2024 | 1.26 | 1.32 | 1.25 | 1.26 | 82,962 | |
11/13/2024 | 1.27 | 1.42 | 1.25 | 1.31 | 128,163 | |
11/12/2024 | 1.25 | 1.34 | 1.18 | 1.29 | 96,095 | |
11/11/2024 | 1.25 | 1.27 | 1.17 | 1.19 | 63,605 | |
11/08/2024 | 1.33 | 1.33 | 1.22 | 1.23 | 106,259 | |
11/07/2024 | 1.30 | 1.38 | 1.25 | 1.36 | 127,845 | |
11/06/2024 | 1.26 | 1.49 | 1.17 | 1.43 | 1,265,954 | |
11/05/2024 | 1.45 | 1.45 | 1.33 | 1.36 | 19,367 | |
11/04/2024 | 1.38 | 1.38 | 1.33 | 1.36 | 31,414 | |
11/01/2024 | 1.33 | 1.37 | 1.32 | 1.35 | 15,269 | |
10/31/2024 | 1.32 | 1.32 | 1.29 | 1.32 | 3,371 | |
10/30/2024 | 1.35 | 1.36 | 1.31 | 1.32 | 10,125 | |
10/29/2024 | 1.35 | 1.35 | 1.30 | 1.35 | 13,593 | |
10/28/2024 | 1.35 | 1.35 | 1.32 | 1.35 | 13,884 | |
10/25/2024 | 1.35 | 1.35 | 1.29 | 1.35 | 22,169 | |
10/24/2024 | 1.41 | 1.41 | 1.34 | 1.35 | 8,049 | |
10/23/2024 | 1.36 | 1.38 | 1.32 | 1.38 | 9,769 | |
10/22/2024 | 1.40 | 1.42 | 1.35 | 1.38 | 16,224 | |
10/21/2024 | 1.45 | 1.45 | 1.38 | 1.40 | 14,116 | |
10/18/2024 | 1.44 | 1.45 | 1.41 | 1.44 | 18,763 | |
10/17/2024 | 1.39 | 1.45 | 1.39 | 1.41 | 13,031 | |
10/16/2024 | 1.39 | 1.43 | 1.34 | 1.43 | 26,554 | |
10/15/2024 | 1.32 | 1.45 | 1.31 | 1.41 | 37,484 | |
10/14/2024 | 1.42 | 1.42 | 1.20 | 1.32 | 74,855 | |
10/11/2024 | 1.34 | 1.40 | 1.31 | 1.37 | 11,726 | |
10/10/2024 | 1.32 | 1.32 | 1.28 | 1.30 | 23,315 | |
10/09/2024 | 1.35 | 1.39 | 1.31 | 1.36 | 8,960 | |
10/08/2024 | 1.38 | 1.41 | 1.32 | 1.35 | 47,971 | |
10/07/2024 | 1.39 | 1.50 | 1.30 | 1.41 | 51,160 | |
10/04/2024 | 1.33 | 1.34 | 1.28 | 1.30 | 34,320 | |
10/03/2024 | 1.46 | 1.46 | 1.21 | 1.30 | 134,130 | |
10/02/2024 | 1.34 | 1.46 | 1.33 | 1.41 | 53,745 | |
10/01/2024 | 1.31 | 1.46 | 1.29 | 1.31 | 147,331 | |
09/30/2024 | 1.86 | 1.88 | 1.34 | 1.46 | 487,504 | |
09/27/2024 | 1.57 | 1.94 | 1.55 | 1.85 | 370,270 | |
09/26/2024 | 1.55 | 1.65 | 1.54 | 1.54 | 112,040 | |
09/25/2024 | 1.53 | 1.55 | 1.50 | 1.54 | 8,516 | |
09/24/2024 | 1.60 | 1.60 | 1.50 | 1.53 | 50,380 | |
09/23/2024 | 1.59 | 1.60 | 1.53 | 1.59 | 14,365 | |
09/20/2024 | 1.58 | 1.64 | 1.50 | 1.64 | 34,696 | |
09/19/2024 | 1.69 | 1.74 | 1.50 | 1.60 | 70,666 | |
09/18/2024 | 1.60 | 1.76 | 1.60 | 1.62 | 81,790 | |
09/17/2024 | 1.58 | 1.59 | 1.51 | 1.59 | 26,088 | |
09/16/2024 | 1.50 | 1.56 | 1.46 | 1.51 | 18,490 | |
09/13/2024 | 1.49 | 1.50 | 1.46 | 1.48 | 15,870 | |
09/12/2024 | 1.35 | 1.48 | 1.28 | 1.43 | 100,033 | |
09/11/2024 | 1.35 | 1.38 | 1.30 | 1.35 | 53,505 | |
09/10/2024 | 1.23 | 1.28 | 1.18 | 1.26 | 38,660 | |
09/09/2024 | 1.37 | 1.41 | 1.15 | 1.22 | 67,384 | |
09/06/2024 | 1.42 | 1.46 | 1.35 | 1.41 | 8,959 | |
09/05/2024 | 1.41 | 1.42 | 1.37 | 1.38 | 23,196 | |
09/04/2024 | 1.58 | 1.58 | 1.37 | 1.44 | 37,629 | |
09/03/2024 | 1.44 | 1.57 | 1.44 | 1.51 | 35,685 |
About Plus Therapeutics Stock history
Plus Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Plus is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Plus Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Plus Therapeutics stock prices may prove useful in developing a viable investing in Plus Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 3.1 M | 3.3 M | |
Net Loss | -23.3 M | -24.5 M |
Plus Therapeutics Stock Technical Analysis
Plus Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Earnings Calls Now
Earnings CallsCheck upcoming earnings announcements updated hourly across public exchanges |
All Next | Launch Module |
Plus Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Plus Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Plus Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Plus to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0) | |||
Jensen Alpha | (0.10) | |||
Total Risk Alpha | (0.98) | |||
Treynor Ratio | (1.66) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Plus Stock Analysis
When running Plus Therapeutics' price analysis, check to measure Plus Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Plus Therapeutics is operating at the current time. Most of Plus Therapeutics' value examination focuses on studying past and present price action to predict the probability of Plus Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Plus Therapeutics' price. Additionally, you may evaluate how the addition of Plus Therapeutics to your portfolios can decrease your overall portfolio volatility.